China Health Group Inc. (HKG:8225)

Hong Kong · Delayed Price · Currency is HKD

0.1390

0.00 (0.00%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceutical R&D, Registration, Appl. and Testing	26.45M	21.43M	13.09M	83.60M	83.06M
Pharmaceutical R&D, Registration, Appl. and Testing Growth	23.47%	63.67%	-84.34%	0.65%	31.40%
Total	26.45M	21.43M	13.09M	83.60M	83.06M
Total Growth	23.47%	63.67%	-84.34%	0.65%	31.40%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
People's Republic of China (PRC)	26.45M	21.43M	13.09M	83.60M	83.06M
People's Republic of China (PRC) Growth	23.47%	63.67%	-84.34%	0.65%	31.40%
Total	26.45M	21.43M	13.09M	83.60M	83.06M
Total Growth	23.47%	63.67%	-84.34%	0.65%	31.40%

Source: S&P Global Market Intelligence.